HOT TOPICS

Antithrombin Therapy for NSTE ACS

• Deciphering the guidelines
• Selecting the best option for your patients
• Case presentations and discussion by international experts

Hemorrhagic Risk-Profiling in ACS

• Can we predict bleeding?
• Blood transfusion: A therapeutic dilemma
• Reducing bleeding to improve outcomes in ACS and primary PCI
• Platelet inhibition and urgent surgery: Lessons learned

Diabetes and Cardiovascular Disease

• Role of tight glucose control: Lessons from ACCORD
• Insulin sensitizing vs. insulin providing: Which is the therapeutic mainstay?
• Early revascularization therapy in diabetic patients

Multivessel Disease: Making the Right Choice

• PCI vs. CABG: Which is best?
• Hybrid approaches to revascularization
• Medical therapy: The only option for some?

ClinCard Spotlight

• Atrial fibrillation: Drug therapy, catheter ablation, antithrombotics, avoiding pitfalls in cardioversion
• SPECT/PET: Appropriateness criteria
• New technology for circulatory support
• NSTEMI as a complication of illness: Controversies in treatment
• Acute decompensated heart failure: Best practices

More Highlights

• Gender specific differences in antiplatelet therapy?
• Extending the benefits of PCI/CABG
• Management of STEMI complications
• Cell therapy: Promises and pitfalls

Learn from the Experts

• Mild troponin elevation in the ER: What to do?
• Creating a successful primary PCI network
• Master clinicians tackle challenging cases
• CT angiography for chest pain: Ready for the ER?

PLUS
With Full-Access registration, i2 Summit also offers:

• Imaging of vulnerable plaque
• How to treat complex lesions and complex patients
• Interventional pharmacology
• Interactive case presentations and discussions throughout the day on clinical strategies of importance to both interventional and general cardiologists